Ensysce Biosciences (ENSCW) Non-Current Debt (2019 - 2022)

Ensysce Biosciences (ENSCW) has 4 years of Non-Current Debt data on file, last reported at $140148.0 in Q4 2022.

• Non-Current Debt for Q4 2022 came in at $140148.0, down 96.16% year-over-year; the trailing twelve-month figure through Dec 2022 was $140148.0 (down 96.16% YoY), and the FY2022 annual result was $140148.0, down 96.16% from the prior year.
• Non-Current Debt retreated to $140148.0 in Q4 2022 per ENSCW's latest filing, from $1.4 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $3.7 million in Q4 2021 and troughed at $137317.0 in Q2 2022.
• A 4-year average of $1.1 million and a median of $566288.0 in 2019 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2021 and 2022: Non-Current Debt jumped 545.04% in 2021, then tumbled 96.16% in 2022.
• A 4-year view of Non-Current Debt shows it stood at $566288.0 in 2019, then changed by 0.0% to $566288.0 in 2020, then jumped by 545.04% to $3.7 million in 2021, then plunged by 96.16% to $140148.0 in 2022.
• Business Quant data shows ENSCW's Non-Current Debt at $140148.0 in Q4 2022, $1.4 million in Q3 2022, and $137317.0 in Q2 2022.